Annual Accounts Receivable
$13.33 M
+$4.42 M+49.56%
December 31, 2021
Summary
- As of February 10, 2025, OPNT annual accounts receivable is $13.33 million, with the most recent change of +$4.42 million (+49.56%) on December 31, 2021.
- During the last 3 years, OPNT annual accounts receivable has risen by +$8.84 million (+196.87%).
Performance
OPNT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Receivable
$41.10 K
-$2.29 M-98.24%
September 30, 2022
Summary
- As of February 10, 2025, OPNT quarterly accounts receivable is $41.10 thousand, with the most recent change of -$2.29 million (-98.24%) on September 30, 2022.
- Over the past year, OPNT quarterly accounts receivable has dropped by -$15.38 million (-99.73%).
Performance
OPNT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
OPNT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +49.6% | -99.7% |
| 3 y3 years | +196.9% | -99.7% |
| 5 y5 years | +13.9% | +100.0% |
OPNT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -99.7% | at low |
| 5 y | 5-year | at high | -45.8% | -99.7% | at low |
| alltime | all time | at high | -97.7% | -99.7% | -100.0% |
Opiant Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $41.10 K(-98.2%) |
| Jun 2022 | - | $2.34 M(-47.5%) |
| Mar 2022 | - | $4.45 M(-66.6%) |
| Dec 2021 | $13.33 M(+49.6%) | $13.33 M(-13.6%) |
| Sep 2021 | - | $15.43 M(+58.6%) |
| Jun 2021 | - | $9.73 M(+73.4%) |
| Mar 2021 | - | $5.61 M(-37.1%) |
| Dec 2020 | $8.91 M(+23.4%) | $8.91 M(+3.5%) |
| Sep 2020 | - | $8.61 M(+37.0%) |
| Jun 2020 | - | $6.29 M(+49.5%) |
| Mar 2020 | - | $4.21 M(-41.7%) |
| Dec 2019 | $7.22 M | $7.22 M(-55.1%) |
| Sep 2019 | - | $16.07 M(+269.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $4.34 M(+122.1%) |
| Mar 2019 | - | $1.96 M(-56.4%) |
| Dec 2018 | $4.49 M(-61.6%) | $4.49 M(+9.2%) |
| Sep 2018 | - | $4.11 M(+38.5%) |
| Jun 2018 | - | $2.97 M(+80.1%) |
| Mar 2018 | - | $1.65 M(>+9900.0%) |
| Dec 2017 | $11.70 M(+211.9%) | - |
| Oct 2017 | - | $0.00(-100.0%) |
| Jul 2017 | $3.75 M(+1100.0%) | $3.75 M(>+9900.0%) |
| Apr 2017 | - | $0.00(0.0%) |
| Jan 2017 | - | $0.00(-100.0%) |
| Oct 2016 | - | $699.10 K(+123.7%) |
| Jul 2016 | $312.50 K | $312.50 K |
FAQ
- What is Opiant Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual accounts receivable year-on-year change?
- What is Opiant Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Opiant Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of OPNT is $13.33 M
What is the all time high annual accounts receivable for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual accounts receivable is $13.33 M
What is Opiant Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, OPNT annual accounts receivable has changed by +$4.42 M (+49.56%)
What is Opiant Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of OPNT is $41.10 K
What is the all time high quarterly accounts receivable for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly accounts receivable is $16.07 M
What is Opiant Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, OPNT quarterly accounts receivable has changed by -$15.38 M (-99.73%)